American Century Companies’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

American Century Companies’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-108,609	Closed	-$1.08M	–	1468
2015 Q2	$1.08M	Buy	108,609 +19,819	+22%	+$213K	﹤0.01%	1135
2015 Q1	$1.13M	Sell	88,790 -282	-0.3%	-$3.63K	﹤0.01%	1132
2014 Q4	$1.26M	Buy	89,072 +17,154	+24%	+$266K	﹤0.01%	1159
2014 Q3	$989K	Buy	71,918 +3,334	+5%	+$51K	﹤0.01%	1187
2014 Q2	$1.05M	Sell	68,584 -2,380	-3%	-$33.7K	﹤0.01%	1206
2014 Q1	$1.21M	Sell	70,964 -5,230	-7%	-$78.9K	﹤0.01%	1189
2013 Q4	$987K	Sell	76,194 -18,720	-20%	-$224K	﹤0.01%	1250
2013 Q3	$959K	Buy	94,914 +5,760	+6%	+$51.3K	﹤0.01%	1240
2013 Q2	$666K	Buy	+89,154	New	+$697K	﹤0.01%	1293

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

American Century Companies's KERX Position: Q3 2015 in Review

American Century Companies sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 108,609 shares — an estimated $1.08M sold.

American Century Companies first reported a position in KERX in Q2 2013 and held it in 9 quarters. The position peaked at $1.26M in Q4 2014. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

American Century Companies reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
American Century Companies sold 108,609 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $1.08M.
American Century Companies first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
American Century Companies's Keryx Biopharmaceuticals Inc position peaked at $1.26M in Q4 2014.
138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on American Century Companies's 13F filing for Q3 2015, filed 2 Nov 2015.